The retinal pigment epithelium (RPE) is a highly specialized, unique epithelial cell that
interacts with photoreceptors on its apical side and with Bruch's membrane and the …

Age-related macular degeneration (AMD) is a common irreversible ocular disease
characterized by vision impairment among older people. Many risk factors are related to …

Purpose Age-related macular degeneration (AMD) is a leading cause of blindness,
particularly in higher-income countries. Although dry AMD accounts for 85% to 90% of AMD …

Introduction With the recent FDA approvals of pegcetacoplan (SYFOVRE, Apellis
Pharmaceuticals) and avacincaptad pegol (IZERVAY, Astellas Pharmaceuticals) …

Age-related macular degeneration (AMD) is a neurodegenerative disease of the aging
retina, in which patients experience severe vision loss. Therapies available to patients are …

Background: Neovascular age-related macular degeneration (AMD) has a poor prognosis if
left untreated, frequently resulting in legal blindness. Ranibizumab is approved for treating …

Purpose To describe the incidence, features, management, and risk factors of post-
intravitreal anti-VEGF endophthalmitis (PIAE) in patients undergoing treatment for exudative …

Oxidative stress has been hypothesized to contribute to the development of age-related
macular degeneration (AMD), the most common cause of blindness in the United States. At …

Abstract Age-related Macular Degeneration (AMD) is the leading cause of blindness among
the elderly in western societies. While antioxidant micronutrient treatment is available for …

Age-related macular degeneration (AMD) is a complex disease caused by genetic and
environmental factors, including genetic variants in complement components and smoking …